GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,011,000 | -7.8% | 1,095,810 | 0.0% | 0.21% | +20.5% |
| Q1 2022 | $37,959,000 | +40.8% | 1,095,810 | +19.0% | 0.17% | +69.3% |
| Q4 2021 | $26,952,000 | -8.9% | 920,810 | -20.7% | 0.10% | -16.5% |
| Q3 2021 | $29,580,000 | +12.6% | 1,160,900 | +54.8% | 0.12% | +6.1% |
| Q2 2021 | $26,265,000 | -14.1% | 750,000 | 0.0% | 0.11% | -39.7% |
| Q1 2021 | $30,563,000 | +41.1% | 750,000 | +50.0% | 0.19% | +44.3% |
| Q4 2020 | $21,655,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |